The midstage clinical trial of the weight
loss drug APD356 developed by Arena Pharmaceuticals Inc. has
shown positive results. The drug was well tolerated at all
doses and had no apparent side effects on heart valves or
pulmonary artery pressure according to its manufacturer. After
using the diet drug for a period of 12 weeks, patients showed
a statistically significant amount of weight loss.
According to the report of the clinical trial, the user of
the drug dropped an average of 4 pounds, 5.7 pounds and 7.9
pounds at respective daily doses of 10 milligrams, 15 milligrams
and 20 milligrams. As far as the result of the clinical trial
goes, the diet pill is going to provide immense relief to
a huge number of people vying for weight loss.
Read the complete news article here:
http://news.moneycentral.msn.com
|
